Detection of HER2 amplification in breast carcinomas: comparison of Multiplex Ligation-dependent Probe Amplification (MLPA) and Fluorescence In Situ Hybridization (FISH) combined with automated spot counting.

作者: Rens L. H. P. M. van Hezik , Adriaan J. C. van den Brule , Toine C. J. M. van der Aa , Elna Moerland , Mike W. P. M. van Beek

DOI: 10.1155/2006/741586

关键词: Multiplex ligation-dependent probe amplificationFish <Actinopterygii>Gene duplicationNucleic acid amplification techniqueBiologyHER2 AmplificationFluorescence in situ hybridizationHercepTestMultiplexMolecular biology

摘要: In this study the detection of HER2 gene amplification was evaluated using Fluorescence Situ Hybridization (FISH; PathVysion) in comparison with Multiplex Ligation-dependent Probe Amplification (MLPA), a PCR based technique. These two methods were on series 46 formalin fixed paraffin embedded breast carcinomas, previously tested for protein overexpression by HercepTest (grouped into Hercep 1+, 2+ and 3+). (ratio ≥ 2.0) FISH found 9/10, 10/30 0/6 IHC 3+, 1+/0 cases, respectively. Digitalized automated spot counting performed recently developed CW4000 CytoFISH software 100% concordant manual scoring. Using MLPA 18/46 samples showed clear amplification. Comparing same results as IHC. All but one positive cases (18/19) confirmed presence The overall concordance Her2 98% (45/46). Furthermore, both level equivocal correlated well between methods. conclusion, is reliable reproducible technique can be used an either alternative or additional test to determine status carcinomas.

参考文章(23)
J A Fletcher, J S Ross, HER-2/neu (c-erb-B2) gene and protein in breast cancer. American Journal of Clinical Pathology. ,vol. 112, ,(1999)
Lise Mette Gjerdrum, Boe Sandahl Sorensen, Eigil Kjeldsen, Flemming Brandt Sorensen, Ebba Nexo, Stephen Hamilton-Dutoit, Real-Time Quantitative PCR of Microdissected Paraffin-Embedded Breast Carcinoma The Journal of Molecular Diagnostics. ,vol. 6, pp. 42- 51 ,(2004) , 10.1016/S1525-1578(10)60490-4
Michael F. Press, Dennis J. Slamon, Kerry J. Flom, Jinha Park, Jian-Yuan Zhou, Leslie Bernstein, Evaluation of HER-2/neu Gene Amplification and Overexpression: Comparison of Frequently Used Assay Methods in a Molecularly Characterized Cohort of Breast Cancer Specimens Journal of Clinical Oncology. ,vol. 20, pp. 3095- 3105 ,(2002) , 10.1200/JCO.2002.09.094
Minoru Takata, Takefumi Suzuki, Shinichi Ansai, Tetsunori Kimura, Fumiaki Shirasaki, Naohito Hatta, Toshiaki Saida, Genome profiling of melanocytic tumors using multiplex ligation-dependent probe amplification (MLPA): Its usefulness as an adjunctive diagnostic tool for melanocytic tumors Journal of Dermatological Science. ,vol. 40, pp. 51- 57 ,(2005) , 10.1016/J.JDERMSCI.2005.06.009
Angelo Di Leo, Mitch Dowsett, Bruce Horten, Frédérique Penault-Llorca, Current status of HER2 testing. Oncology. ,vol. 63, pp. 25- 32 ,(2002) , 10.1159/000066204
Marcory C van Dijk, Paul D Rombout, Sandra H Boots-Sprenger, Huub Straatman, Monique R Bernsen, Dirk J Ruiter, Judith W Jeuken, Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagnostic Molecular Pathology. ,vol. 14, pp. 9- 16 ,(2005) , 10.1097/01.PAS.0000146701.98954.47
Loryn N. Sellner, Graham R. Taylor, MLPA and MAPH: New techniques for detection of gene deletions Human Mutation. ,vol. 23, pp. 413- 419 ,(2004) , 10.1002/HUMU.20035
Priti Lal, Paulo A. Salazar, Marc Ladanyi, Beiyun Chen, Impact of Polysomy 17 on HER-2/neu Immunohistochemistry in Breast Carcinomas without HER-2/neu Gene Amplification The Journal of Molecular Diagnostics. ,vol. 5, pp. 155- 159 ,(2003) , 10.1016/S1525-1578(10)60467-9